Update Breast Cancer 2021 Part 4 – Prevention and Early Stages

This past year has seen new and effective options for further improving treatment outcome in many patients with early-stage breast cancer. Patients with hormone receptor-positive disease benefited significantly from the addition of the CDK4/6 inhibitor abemaciclib to endocrine adjuvant therapy. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomssen, Christoph, Fehm, Tanja N., Stickeler, Elmar, Fasching, Peter A., Janni, Wolfgang, Kolberg-Liedtke, Cornelia, Kolberg, Hans-Christian, Lüftner, Diana, Müller, Volkmar, Schütz, Florian, Belleville, Erik, Bader, Simon, Untch, Michael, Welslau, Manfred, Thill, Marc, Hartkopf, Andreas D., Tesch, Hans, Ditsch, Nina, Lux, Michael P., Wöckel, Achim, Aktas, Bahriye, Schneeweiss, Andreas, Würstlein, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837401/
https://www.ncbi.nlm.nih.gov/pubmed/35169388
http://dx.doi.org/10.1055/a-1724-9639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837401/
https://www.ncbi.nlm.nih.gov/pubmed/35169388
http://dx.doi.org/10.1055/a-1724-9639

Ejemplares similares